Fate Therapeutics Inc (NAS:FATE) Stock News, Headlines & Updates
Fate Therapeutics Inc Stock News from GuruFocus
- 1
Jul 02, 2024
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Jun 13, 2024
FATE SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Fate Therapeutics, Inc. (NASDAQ: FATE) and Encourages Long-Term FATE Investors to Contact the Firm
PRNewswire • 8:00am
Jun 04, 2024
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
May 29, 2024
Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference
Marketwired • 4:00pm
May 10, 2024
Fate Therapeutics Inc (FATE) Q1 2024 Earnings: Mixed Financial Performance Amid Clinical Advancements
GuruFocus Research • 12:50pm
May 09, 2024
Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program
Marketwired • 8:00am
May 06, 2024
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates
Marketwired • 7:00am
May 03, 2024
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
Marketwired • 4:00pm
Apr 22, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news